相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MANAGEMENT OF ENDOCRINE DISEASE Novel anabolic treatments for osteoporosis
Ernesto Canalis
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Recombinant sclerostin antagonizes effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size
M. Kogawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
DKK1 and sclerostin are early markers of relapse in multiple myeloma
Charlotte Mabille et al.
BONE (2018)
Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists
Gill Holdsworth et al.
BONE (2018)
Ex vivo replication of phenotypic functions of osteocytes through biomimetic 3D bone tissue construction
Qiaoling Sun et al.
BONE (2018)
Structural and functional analysis of Dickkopf 4 (Dkk4): New insights into Dkk evolution and regulation of Wnt signaling by Dkk and Kremen proteins
Saleha Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
SOST/Sclerostin Improves Posttraumatic Osteoarthritis and Inhibits MMP2/3 Expression After Injury
Jiun C. Chang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Mechanically induced Ca2+ oscillations in osteocytes release extracellular vesicles and enhance bone formation
Andrea E. Morrell et al.
BONE RESEARCH (2018)
Current knowledge on exosome biogenesis and release
Nina Pettersen Hessvik et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis
Smriti Murali Krishna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms
Abhishek Chandra et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys
Michael S. Ominsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Emerging anabolic agents in the treatment of osteoporosis
Christina Lovato et al.
EXPERT OPINION ON EMERGING DRUGS (2017)
Activating the unfolded protein response in osteocytes causes hyperostosis consistent with craniodiaphyseal dysplasia
Wilson Cheuk Wing Chan et al.
HUMAN MOLECULAR GENETICS (2017)
Radial artery sclerostin expression in chronic kidney disease stage 5 predialysis patients: a cross-sectional observational study
Hua Zhou et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2017)
Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts
Sang Wan Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
The Skeleton Is a Storehouse of Mineral That Is Plundered During Lactation and (Fully?) Replenished Afterwards
Christopher S. Kovacs
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Skeletal energy homeostasis: a paradigm of endocrine discovery
Karla J. Suchacki et al.
JOURNAL OF ENDOCRINOLOGY (2017)
Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth
J. Delgado-Calle et al.
LEUKEMIA (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes
Soohyun P. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Bone CLARITY: Clearing, imaging, and computational analysis of osteoprogenitors within intact bone marrow
Alon Greenbaum et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential
Michael R. McClung
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2017)
Bone quality changes associated with aging and disease: a review
Adele L. Boskey et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Ex vivo construction of human primary 3D-networked osteocytes
Qiaoling Sun et al.
BONE (2017)
Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys
Rogely Waite Boyce et al.
BONE (2017)
Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta
David G. Little et al.
BONE (2017)
Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma
Michelle M. McDonald et al.
BLOOD (2017)
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Roel Nusse et al.
CELL (2017)
Sclerostin deficiency in humans
Antoon H. van Lierop et al.
BONE (2017)
Effects of sclerostin antibodies in animal models of osteoporosis
Michael Stuart Ominsky et al.
BONE (2017)
The systemic effects of sclerostin overexpression using ΦC31 integrase in mice
Dongdong Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats
Scott Taylor et al.
BONE (2016)
Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells
Nicole M. Collette et al.
BONE (2016)
Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma
Jesus Delgado-Calle et al.
CANCER RESEARCH (2016)
Osteocytes: The master cells in bone remodelling
Matthew Prideaux et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin
Amy Y. Sato et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
Homare Eda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone
Igor Fijalkowski et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study
Luc Chouinard et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Structural and functional insights into sclerostin-glycosaminoglycan interactions in bone
Juliane Salbach-Hirsch et al.
BIOMATERIALS (2015)
Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats
Michael S. Ominsky et al.
BONE (2015)
Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia
Zahra Achiou et al.
BONE (2015)
LRP5 Regulates Human Body Fat Distribution by Modulating Adipose Progenitor Biology in a Dose- and Depot-Specific Fashion
Nellie Y. Loh et al.
CELL METABOLISM (2015)
Removal of SOST or blocking its product sclerostin rescues defects in the periodontitis mouse model
Yinshi Ren et al.
FASEB JOURNAL (2015)
The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro
Jordan M. Spatz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats
Weiping Qin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5
Timur A. Yorgan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
The WNT system: background and its role in bone
U. H. Lerner et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone
Xiaolin Tu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways
Wafa Bouaziz et al.
ARTHRITIS RESEARCH & THERAPY (2015)
An Overview of the Metabolic Functions of Osteocalcin
Jianwen Wei et al.
CURRENT OSTEOPOROSIS REPORTS (2015)
Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans
Matthew M. Roforth et al.
BONE (2014)
Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats
Marina Stolina et al.
BONE (2014)
Bone marrow plasma macrophage inflammatory protein protein-1 alpha(MIP-1 alpha) and sclerostin in multiple myeloma: Relationship with bone disease and clinical characteristics
Xiao-Tao Wang et al.
LEUKEMIA RESEARCH (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
Ming-Kang Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury
Martine Roudier et al.
ARTHRITIS AND RHEUMATISM (2013)
Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling
Shane A. Lloyd et al.
BONE (2013)
Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading
Jordan M. Spatz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Sclerostin Regulates Release of Bone Mineral by Osteocytes by Induction of Carbonic Anhydrase 2
Masakazu Kogawa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
Early Response of Bone Marrow Osteoprogenitors to Skeletal Unloading and Sclerostin Antibody
Mohammad Shahnazari et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
Hua Zhu Ke et al.
ENDOCRINE REVIEWS (2012)
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post-bortezomib monotherapy
Evangelos Terpos et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors
Gill Holdsworth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
Karin Amrein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The complex world of WNT receptor signalling
Christof Niehrs
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Sclerostin is overexpressed by plasma cells from multiple myeloma patients
Giacomina Brunetti et al.
SKELETAL BIOLOGY AND MEDICINE I (2011)
Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia
Su Jin Kim et al.
HUMAN GENETICS (2011)
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Olivier Leupin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cell Line IDG-SW3 Replicates Osteoblast-to-Late-Osteocyte Differentiation In Vitro and Accelerates Bone Formation In Vivo
Stacey M. Woo et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Sclerostin Is a Locally Acting Regulator of Late-Osteoblast/Preosteocyte Differentiation and Regulates Mineralization Through a MEPE-ASARM-Dependent Mechanism
Gerald J. Atkins et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis
B. Y. Chan et al.
OSTEOARTHRITIS AND CARTILAGE (2011)
The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
Dongxing Zhu et al.
PLOS ONE (2011)
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Asiri R. Wijenayaka et al.
PLOS ONE (2011)
Wnt Antagonists Bind through a Short Peptide to the First β-Propeller Domain of LRP5/6
Eric Bourhis et al.
STRUCTURE (2011)
Myeloma cells suppress osteoblasts through sclerostin secretion
S. Colucci et al.
BLOOD CANCER JOURNAL (2011)
Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
Carola Krause et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Reconstitution of a Frizzled8.Wnt3a.LRP6 Signaling Complex Reveals Multiple Wnt and Dkk1 Binding Sites on LRP6
Eric Bourhis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Sclerostin: A Gem From the Genome Leads to Bone-Building Antibodies
Chris Paszty et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Proteomics Characterization of Extracellular Space Components in the Human Aorta
Athanasios Didangelos et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies
Seth A. Ettenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
NMR structure of the Wnt modulator protein Sclerostin
Stella E. Weidauer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Characterization of the Structural Features and Interactions of Sclerostin MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION
Vaclav Veverka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β-Catenin Signaling
Chuwen Lin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sclerostin in Mineralized Matrices and van Buchem Disease
R. L. van Bezooijen et al.
JOURNAL OF DENTAL RESEARCH (2009)
Osteocyte Remodeling of the Perilacunar and Pericanalicular Matrix
Hai Qing et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2009)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin
Alexander G. Robling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development
Rutger L. van Bezooijen et al.
DEVELOPMENTAL DYNAMICS (2007)
LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST
Mikhail V. Semenov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
KES Poole et al.
FASEB JOURNAL (2005)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
GG Loots et al.
GENOME RESEARCH (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation
MK Sutherland et al.
BONE (2004)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density
L Van Wesenbeeck et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
W Balemans et al.
JOURNAL OF MEDICAL GENETICS (2002)
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
YQ Gong et al.
CELL (2001)
Establishment of an osteoid preosteocyte-like cell MLO-A5 that spontaneously mineralizes in culture
Y Kato et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
